Tubeimoside I is an anti-tumor agent. It acts by inducing cell cycle arrest and apoptosis, activating caspase, p53 Fas, TNFa, NF-kB and JNK pathways, and regulating Bcl-2, Bak and Bax. References: Zhang JB, Zhang L, Li SQ, Hou AH, Liu WC, Dai LL. Tubeimoside I attenuates inflammation and oxidative damage in a mice model of PM(2.5)-induced pulmonary injury. Exp Ther Med. 2018 Feb;15(2):1602-1607. doi: 10.3892/etm.2017.5597. Epub 2017 Dec 5. PubMed PMID: 29434745; PubMed Central PMCID: PMC5776624.

纯度：≥98%

CAS：102040-03-9